Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Centessa Pharmaceuticals plc

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsJun-30-23Mar-31-23Jun-30-22Mar-31-22Dec-31-21Sep-30-21
   10-Q10-Q10-Q10-Q8-K10-Q
Revenues    39.628.2  
Cost of goods sold    86.886.8  
Gross profit    -47.3-58.6  
            Gross margin    -119.5%-207.5%  
Selling, general and administrative   [+]  54.651.7  
Research and development    116.480.8  
EBITDA    -218.2-191.1  
            EBITDA margin    -551.6%-676.6%  
Depreciation and amortization    0.10.0  
EBIT    -218.2-191.1  
            EBIT margin    -551.7%-676.7%  
Interest expense    4.42.7  
Other income (expense), net   [+]  2.7-2.9  
Pre-tax income    -219.9-196.7  
Income taxes    0.20.2  
            Tax rate    -0.1%   
Net income    -220.1-196.9  
            Net margin    -556.4%-697.1%  
   
Basic EPS    ($3.21)($3.23)  
Diluted EPS    ($3.21)($3.23)  
   
Shares outstanding (basic)    68.661.0  
Shares outstanding (diluted)    68.661.0  
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy